An article referencing ReachBio's new drug screening platform to discover therapeutic compounds that trigger the production of fetal hemoglobin (HbF) to treat sickle cell disease (SCD) and other blood disorders is prominently featured on the Sickle Cell Anemia News website. Please click the link to read the full article by Ana Pena, PhD.

Our lab is beyond delighted to be recognized by a publication whose editorial staff is focused on providing fresh and informative news stories that reach a broad readership who have the sole goal of finding an effective treatment that can cure sickle cell disease.  We believe the cure is closer because of the effort of all of the characters in the sickle cell anemia research community and are proud to play the humblest of roles.